We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+5.35%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$550M
AUM Growth
+$22.8M
Cap. Flow
+$2.65M
Cap. Flow %
0.48%
Top 10 Hldgs %
26.41%
Holding
224
New
15
Increased
50
Reduced
74
Closed
34

Sector Composition

Rank Sector Weight
1 Healthcare 20.69%
2 Technology 16.92%
3 Financials 15.12%
4 Consumer Discretionary 9.03%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
151
Lockheed Martin
LMT
$135B
$300K 0.05%
1,251
COF icon
152
Capital One
COF
$134B
$295K 0.05%
4,100
LNC icon
153
Lincoln National
LNC
$8.82B
$290K 0.05%
6,170
+112
+2% +$5.01K
AAN.A
154
DELISTED
The Aaron's Company Inc Class A
AAN.A
$286K 0.05%
11,250
PSX icon
155
Phillips 66
PSX
$82.7B
$284K 0.05%
3,521
PGEN icon
156
Precigen
PGEN
$2.36B
$280K 0.05%
10,090
HPE icon
157
Hewlett Packard
HPE
$66.5B
$274K 0.05%
20,733
FPRX
158
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$262K 0.05%
+5,000
New +$239K
CMCSA icon
159
Comcast
CMCSA
$87.2B
$260K 0.05%
7,846
LOB icon
160
Live Oak Bancshares
LOB
$2.03B
$259K 0.05%
17,975
WMB icon
161
Williams Companies
WMB
$86.1B
$249K 0.05%
+8,109
New +$215K
JCI icon
162
Johnson Controls International
JCI
$88.7B
$233K 0.04%
5,014
-716
-12% -$33.2K
EBAY icon
163
eBay
EBAY
$47.6B
$229K 0.04%
+6,965
New +$210K
LNT icon
164
Alliant Energy
LNT
$18.4B
$224K 0.04%
5,847
-767
-12% -$30.1K
TOVX icon
165
Theriva Biologics
TOVX
$10.2M
$217K 0.04%
14
BCRX icon
166
BioCryst Pharmaceuticals
BCRX
$2.24B
$216K 0.04%
49,000
-20,000
-29% -$79.9K
ATRA icon
167
Atara Biotherapeutics
ATRA
$77M
$214K 0.04%
+400
New +$217K
ACN icon
168
Accenture
ACN
$101B
$200K 0.04%
+1,639
New +$187K
HPQ icon
169
HP
HPQ
$24.8B
$187K 0.03%
12,050
-1,000
-8% -$14.3K
VIRX
170
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$146K 0.03%
952
PSTB
171
DELISTED
Park Sterling Corp.
PSTB
$125K 0.02%
15,384
SCPX
172
DELISTED
Scorpius Holdings, Inc.
SCPX
0
FTR
173
DELISTED
Frontier Communications Corp.
FTR
$83K 0.02%
1,337
-4
-0.3% -$285
PDLI
174
DELISTED
PDL BioPharma, Inc.
PDLI
$75K 0.01%
22,500
-15,000
-40% -$47.6K
RIGL icon
175
Rigel Pharmaceuticals
RIGL
$693M
$73K 0.01%
2,000

Similar funds

Franklin Street Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Franklin Street Advisors held 224 positions worth $550M, up 4.3% from $527M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Franklin Street Advisors's Q3 2016 filing shows 15 new, 50 increased, 74 reduced and 34 closed positions. Its largest new stake was Kohl's: 127,056 shares worth $5.56M. The largest sale was LinkedIn Corporation, an estimated $4.78M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Franklin Street Advisors's largest Q3 2016 buy was Kohl's: 127,056 shares worth $5.56M.
  • Franklin Street Advisors added most to Meta Platforms (Facebook) in Q3 2016, an estimated $4.16M increase.
  • Franklin Street Advisors's biggest Q3 2016 reduction was W.W. Grainger, cutting an estimated $3.11M.
  • Franklin Street Advisors fully exited LinkedIn Corporation in Q3 2016, selling an estimated $4.78M.
  • Franklin Street Advisors's ten largest holdings make up 26% of its $550M portfolio in Q3 2016.
  • Franklin Street Advisors opened 15 new positions and closed 34 in Q3 2016.
  • Franklin Street Advisors's portfolio value rose 4.3% quarter-over-quarter to $550M.

Based on Franklin Street Advisors's 13F filing for Q3 2016, filed 5 Oct 2016.